TBPH Research and Charts

TBPH - Theravance Biopharma Inc (Healthcare: Biotechnology)

Projected Earnings Date: 2024-08-09 (Delayed quote data 2025-06-30)

Last 11.03	Change ⇓ -0.19 (-1.69%)	Volume 208,255
	Open 11.22	High 11.37	Low 11.00

8EMA (Daily) 10.83	40EMA (Daily) 10.25	50EMA (Daily) 10.12	STO (Daily) 40.980	MACD Hist (Daily) 0.010
8EMA (Weekly) 10.485	40EMA (Weekly) 9.58	50EMA (Weekly) 9.52	STO (Weekly) 78.163	MACD Hist (Weekly) 0.394


Company Profile
Theravance Biopharma is a diversified biotechnology company that creates medicines to treat serious illnesses. The company's research and development are concentrated primarily on four therapeutic areas-infectious disease, respiratory, gastrointestinal disease, and cardiovascular and renal disease. Its commercial infrastructure is focused primarily on the acute care setting. The company uses strategic collaboration with other industry players. Theravance generates the majority of its revenue in the U.S. and Europe, followed by Asia.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.